Transforming Ovarian Cancer Care by Targeting Minimal Residual Disease

Authors

Amir A Jazaeri
Rachel Grisham
Anne Knisely
Stefani Spranger
Dmitriy Zamarin
R Tyler Hillman
Barrett C Lawson
Kathleen H Burns
Sanghoon Lee
Shannon N Westin
Enrico Moiso
Marc J Williams
Neelkanth M Bardhan
Thomas Pisanic
Ursula Matulonis
Britta Weigelt
IeMing Shih
Panagiotis A Konstantinopoulos
Stephanie Gaillard
Linghua Wang
Carol Aghajanian
Alan D D'Andrea
Paula Hammond
Sohrab Shah
Kai W Wucherpfennig
Karen H Lu

Publication Date

11-10-2023

Journal

Med

DOI

10.1016/j.medj.2023.08.004

PMID

37951209

PMCID

PMC11275633

PubMedCentral® Posted Date

July 2024

PubMedCentral® Full Text Version

Author MSS

Abstract

Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

Keywords

Humans, Female, Neoplasm, Residual, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial

Published Open-Access

yes

Recommended Citation

Jazaeri, Amir A; Grisham, Rachel; Knisely, Anne; et al., "Transforming Ovarian Cancer Care by Targeting Minimal Residual Disease" (2023). Faculty, Staff and Student Publications. 1186.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/1186